HMG-CoA reductase inhibitors inhibit pan-cancer epithelial-mesenchymal transition by targeting XBP1+ mast cells

Name: HMG-CoA reductase inhibitors inhibit pan-cancer epithelial-mesenchymal transition by targeting XBP1+ mast cells
Creator: Lisheng Peng
Published: 2024-06-24T09:11:41.025Z
Keywords: Cancer Immunology, Mast Cell

Peng, Lisheng

doi:10.17632/dwf7ccphpz.1

HMG-CoA reductase inhibitors inhibit pan-cancer epithelial-mesenchymal transition by targeting XBP1+ mast cells

Published: 24 June 2024| Version 1 | DOI: 10.17632/dwf7ccphpz.1

Contributor:

Lisheng Peng

Description

HMG-CoA reductase inhibitors inhibit pan-cancer epithelial-mesenchymal transition by targeting XBP1+ mast cells

Files

Institutions

Guangzhou University of Chinese Medicine

HMG-CoA reductase inhibitors inhibit pan-cancer epithelial-mesenchymal transition by targeting XBP1+ mast cells

Description

Files

Institutions

Categories

Licence